Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Rossin F, Villella VR, D'Eletto M, Farrace MG, Esposito S, Ferrari E, Monzani R, Occhigrossi L, Pagliarini V, Sette C, Cozza G, Barlev NA, Falasca L, Fimia GM, Kroemer G, Raia V, Maiuri L, Piacentini M.

EMBO Rep. 2018 May 11. pii: e45067. doi: 10.15252/embr.201745067. [Epub ahead of print]

PMID:
29752334
2.

Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses.

D'Eletto M, Farrace MG, Piacentini M, Rossin F.

Methods Enzymol. 2017;587:511-520. doi: 10.1016/bs.mie.2016.10.011. Epub 2016 Nov 29.

PMID:
28253975
3.

Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions.

Diaz-Hidalgo L, Altuntas S, Rossin F, D'Eletto M, Marsella C, Farrace MG, Falasca L, Antonioli M, Fimia GM, Piacentini M.

Biochim Biophys Acta. 2016 Aug;1863(8):2084-92. doi: 10.1016/j.bbamcr.2016.05.005. Epub 2016 May 8.

4.

The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.

Altuntas S, Rossin F, Marsella C, D'Eletto M, Diaz-Hidalgo L, Farrace MG, Campanella M, Antonioli M, Fimia GM, Piacentini M.

Oncotarget. 2015 Dec 29;6(42):44941-54. doi: 10.18632/oncotarget.6759.

5.

Transglutaminase type 2: A multifunctional protein chaperone?

Rossin F, D'Eletto M, Farrace MG, Piacentini M.

Mol Cell Oncol. 2014 Dec 31;1(4):e968506. doi: 10.4161/23723548.2014.968506. eCollection 2014 Oct-Dec.

6.

Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois.

Altuntas S, D'Eletto M, Rossin F, Hidalgo LD, Farrace MG, Falasca L, Piredda L, Cocco S, Mastroberardino PG, Piacentini M, Campanella M.

Mitochondrion. 2014 Nov;19 Pt A:97-104. doi: 10.1016/j.mito.2014.09.008. Epub 2014 Sep 28. Review.

PMID:
25262960
7.

Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states.

Piacentini M, D'Eletto M, Farrace MG, Rodolfo C, Del Nonno F, Ippolito G, Falasca L.

Cell Tissue Res. 2014 Dec;358(3):793-805. doi: 10.1007/s00441-014-1990-x. Epub 2014 Sep 11.

8.

Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis.

Rossin F, D'Eletto M, Falasca L, Sepe S, Cocco S, Fimia GM, Campanella M, Mastroberardino PG, Farrace MG, Piacentini M.

Cell Death Differ. 2015 Mar;22(3):408-18. doi: 10.1038/cdd.2014.106. Epub 2014 Jul 25.

9.

Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins.

D'Eletto M, Farrace MG, Rossin F, Strappazzon F, Giacomo GD, Cecconi F, Melino G, Sepe S, Moreno S, Fimia GM, Falasca L, Nardacci R, Piacentini M.

Cell Death Differ. 2012 Jul;19(7):1228-38. doi: 10.1038/cdd.2012.2. Epub 2012 Feb 10.

10.

Transglutaminase 2 at the crossroads between cell death and survival.

Piacentini M, D'Eletto M, Falasca L, Farrace MG, Rodolfo C.

Adv Enzymol Relat Areas Mol Biol. 2011;78:197-246. Review. No abstract available.

PMID:
22220475
11.

Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance.

de Luca A, Moroni N, Serafino A, Primavera A, Pastore A, Pedersen JZ, Petruzzelli R, Farrace MG, Pierimarchi P, Moroni G, Federici G, Sinibaldi Vallebona P, Lo Bello M.

Biochem J. 2011 Dec 1;440(2):175-83. doi: 10.1042/BJ20111333.

PMID:
21834791
12.

TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.

Rossin F, D'Eletto M, Macdonald D, Farrace MG, Piacentini M.

Amino Acids. 2012 May;42(5):1793-802. doi: 10.1007/s00726-011-0899-x. Epub 2011 Apr 10.

PMID:
21479826
13.

Transglutaminase 2 is involved in autophagosome maturation.

D'Eletto M, Farrace MG, Falasca L, Reali V, Oliverio S, Melino G, Griffin M, Fimia GM, Piacentini M.

Autophagy. 2009 Nov;5(8):1145-54.

PMID:
19955852
14.

The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis.

Malorni W, Farrace MG, Matarrese P, Tinari A, Ciarlo L, Mousavi-Shafaei P, D'Eletto M, Di Giacomo G, Melino G, Palmieri L, Rodolfo C, Piacentini M.

Cell Death Differ. 2009 Nov;16(11):1480-92. doi: 10.1038/cdd.2009.100. Epub 2009 Jul 31.

15.

Transglutaminase type II is involved in the pathogenesis of endotoxic shock.

Falasca L, Farrace MG, Rinaldi A, Tuosto L, Melino G, Piacentini M.

J Immunol. 2008 Feb 15;180(4):2616-24.

16.

Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection.

Malorni W, Farrace MG, Rodolfo C, Piacentini M.

Curr Pharm Des. 2008;14(3):278-88. Review.

PMID:
18220838
17.

Xeno-cannibalism: a survival "escamotage".

Malorni W, Matarrese P, Tinari A, Farrace MG, Piacentini M.

Autophagy. 2007 Jan-Feb;3(1):75-7. Epub 2007 Jan 28. Review.

PMID:
17172802
18.

Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.

Battaglia G, Farrace MG, Mastroberardino PG, Viti I, Fimia GM, Van Beeumen J, Devreese B, Melino G, Molinaro G, Busceti CL, Biagioni F, Nicoletti F, Piacentini M.

J Neurochem. 2007 Jan;100(1):36-49. Epub 2006 Oct 25.

19.

"Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes.

Mastroberardino PG, Farrace MG, Viti I, Pavone F, Fimia GM, Melino G, Rodolfo C, Piacentini M.

Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1357-65. Epub 2006 Aug 3.

20.

Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease.

Mormone E, Matarrese P, Tinari A, Cannella M, Maglione V, Farrace MG, Piacentini M, Frati L, Malorni W, Squitieri F.

J Neurochem. 2006 Aug;98(4):1090-9.

21.

Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis.

Szondy Z, Mastroberardino PG, Váradi J, Farrace MG, Nagy N, Bak I, Viti I, Wieckowski MR, Melino G, Rizzuto R, Tósaki A, Fesus L, Piacentini M.

Cell Death Differ. 2006 Oct;13(10):1827-9. Epub 2006 Mar 10. No abstract available.

22.

Type 2 transglutaminase and cell death.

Piacentini M, Amendola A, Ciccosanti F, Falasca L, Farrace MG, Mastroberardino PG, Nardacci R, Oliverio S, Piredda L, Rodolfo C, Autuori F.

Prog Exp Tumor Res. 2005;38:58-74. Review. No abstract available.

PMID:
15746529
23.

Tissue transglutaminase is a multifunctional BH3-only protein.

Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, Piredda L, Fimia GM, Malorni W, Piacentini M.

J Biol Chem. 2004 Dec 24;279(52):54783-92. Epub 2004 Oct 12.

24.

Expression of apoptosis-related proteins in rat with induced colitis.

D'Argenio G, Farrace MG, Cosenza V, De Ritis F, Della Valle N, Manguso F, Piacentini M.

Int J Colorectal Dis. 2004 Sep;19(5):451-60. Epub 2004 Apr 9.

PMID:
15083321
25.

Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress.

Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasca L, Rodolfo C, Giammarioli AM, Verderio E, Griffin M, Malorni W.

J Neurochem. 2002 Jun;81(5):1061-72.

26.

Presence of anti-"tissue" transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event?

Farrace MG, Picarelli A, Di Tola M, Sabbatella L, Marchione OP, Ippolito G, Piacentini M.

Cell Death Differ. 2001 Jul;8(7):767-70. No abstract available.

27.

"Tissue" transglutaminase in animal development.

Piacentini M, Rodolfo C, Farrace MG, Autuori F.

Int J Dev Biol. 2000;44(6):655-62. Review.

28.

Bcl-2 and Bax regulation of apoptosis in germ cells during prenatal oogenesis in the mouse embryo.

Felici MD, Carlo AD, Pesce M, Iona S, Farrace MG, Piacentini M.

Cell Death Differ. 1999 Sep;6(9):908-15.

29.

'Tissue' transglutaminase release from apoptotic cells into extracellular matrix during human liver fibrogenesis.

Piacentini M, Farrace MG, Hassan C, Serafini B, Autuori F.

J Pathol. 1999 Sep;189(1):92-8.

PMID:
10451494
30.

Hormonal control of "tissue" transglutaminase induction during programmed cell death in frog liver.

Assisi L, Autuori F, Botte V, Farrace MG, Piacentini M.

Exp Cell Res. 1999 Mar 15;247(2):339-46.

PMID:
10066361
31.

Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis.

Piredda L, Farrace MG, Lo Bello M, Malorni W, Melino G, Petruzzelli R, Piacentini M.

FASEB J. 1999 Feb;13(2):355-64.

PMID:
9973324
32.

"Tissue" transglutaminase and apoptosis.

Autuori F, Farrace MG, Oliverio S, Piredda L, Piacentini M.

Adv Biochem Eng Biotechnol. 1998;62:129-36. Review.

PMID:
9755643
33.

Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.

Oliverio S, Amendola A, Di Sano F, Farrace MG, Fesus L, Nemes Z, Piredda L, Spinedi A, Piacentini M.

Mol Cell Biol. 1997 Oct;17(10):6040-8.

34.

Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice.

Piredda L, Amendola A, Colizzi V, Davies PJ, Farrace MG, Fraziano M, Gentile V, Uray I, Piacentini M, Fesus L.

Cell Death Differ. 1997 Aug;4(6):463-72.

35.

Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis.

Piacentini M, Piredda L, Starace DT, Annicchiarico-Petruzzelli M, Mattei M, Oliverio S, Farrace MG, Melino G.

J Pathol. 1996 Dec;180(4):415-22.

PMID:
9014863
36.

Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriatic skin.

Bianchi L, Farrace MG, Nini G, Piacentini M.

J Invest Dermatol. 1994 Dec;103(6):829-33.

37.
38.

The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).

Piacentini M, Fesus L, Farrace MG, Ghibelli L, Piredda L, Melino G.

Eur J Cell Biol. 1991 Apr;54(2):246-54.

PMID:
1679009
39.

"Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation.

Piacentini M, Autuori F, Dini L, Farrace MG, Ghibelli L, Piredda L, Fesus L.

Cell Tissue Res. 1991 Feb;263(2):227-35.

PMID:
1672508
40.

Ca2(+)-dependence of arachidonic acid redistribution among phospholipids of cultured mouse keratinocytes.

Pacini L, Spinedi A, Piacentini M, Limatola C, Farrace MG, Autuori F, Luly P.

Biochim Biophys Acta. 1990 Aug 6;1045(3):213-8.

PMID:
2117470
41.

Polyamine-dependent post-translational modification of proteins in differentiating mouse epidermal cells.

Piacentini M, Farrace MG, Imparato M, Piredda L, Autuori F.

J Invest Dermatol. 1990 May;94(5):694-9.

42.

Proliferative response of foetal liver peroxisomes to clofibrate treatment of pregnant rats. A quantitative evaluation.

Stefanini S, Mauriello A, Farrace MG, Cibelli A, Ceru MP.

Biol Cell. 1989;67(3):299-305.

PMID:
2620164
43.
44.

Post-translational modifications of cellular proteins by polyamines and polyamine-derivatives.

Piacentini M, Ceru'-Argento MP, Farrace MG, Autuori F.

Adv Exp Med Biol. 1988;231:185-98. Review. No abstract available.

PMID:
3046245
45.
46.

Cytochemical localization of adenylate cyclase activity in parenchymal cells of adult and fetal rat liver.

Stefanini S, Farrace MG, Ciofi Luzzatto A.

Cell Mol Biol. 1983;29(4):291-7. No abstract available.

PMID:
6627294

Supplemental Content

Loading ...
Support Center